128 related articles for article (PubMed ID: 37985938)
1. An Australian mainstream genetic testing program: Clinicians views about current and future practices.
Young AL; Ip E; Scheinberg T; Harrison M; Beale P; Goodwin A
Asia Pac J Clin Oncol; 2024 Feb; 20(1):119-127. PubMed ID: 37985938
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a mainstream genetic testing program for women with ovarian or breast cancer.
Ip E; Young AL; Scheinberg T; Harrison M; Beale P; Goodwin A
Asia Pac J Clin Oncol; 2022 Oct; 18(5):e414-e419. PubMed ID: 35098668
[TBL] [Abstract][Full Text] [Related]
3. A pilot study investigating feasibility of mainstreaming germline BRCA1 and BRCA2 testing in high-risk patients with breast and/or ovarian cancer in three tertiary Cancer Centres in Ireland.
McVeigh TP; Sweeney KJ; Brennan DJ; McVeigh UM; Ward S; Strydom A; Seal S; Astbury K; Donnellan P; Higgins J; Keane M; Kerin MJ; Malone C; McGough P; McLaughlin R; O'Leary M; Rushe M; Barry MK; MacGregor G; Sugrue M; Yousif A; Al-Azawi D; Berkeley E; Boyle TJ; Connolly EM; Nolan C; Richardson E; Giffney C; Doyle SB; Broderick S; Boyd W; McVey R; Walsh T; Farrell M; Gallagher DJ; Rahman N; George AJ
Fam Cancer; 2023 Apr; 22(2):135-149. PubMed ID: 36029389
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a Mainstream Model of Genetic Testing for Men With Prostate Cancer.
Scheinberg T; Goodwin A; Ip E; Linton A; Mak B; Smith DP; Stockler MR; Strach MC; Tran B; Young AL; Zhang AY; Mahon KL; Horvath LG
JCO Oncol Pract; 2021 Feb; 17(2):e204-e216. PubMed ID: 32970524
[TBL] [Abstract][Full Text] [Related]
5. The integration of BRCA testing into oncology clinics.
Percival N; George A; Gyertson J; Hamill M; Fernandes A; Davies E; Rahman N; Banerjee S
Br J Nurs; 2016 Jun; 25(12):690-4. PubMed ID: 27345073
[TBL] [Abstract][Full Text] [Related]
6. Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinics.
Kentwell M; Dow E; Antill Y; Wrede CD; McNally O; Higgs E; Hamilton A; Ananda S; Lindeman GJ; Scott CL
Gynecol Oncol; 2017 Apr; 145(1):130-136. PubMed ID: 28162234
[TBL] [Abstract][Full Text] [Related]
7. Oncologist-led
Yoon SY; Wong SW; Lim J; Ahmad S; Mariapun S; Padmanabhan H; Hassan NT; Lau SY; Ch'ng GS; Haniffa M; Ong WP; Rethanavelu K; Moey LH; Keng WT; Omar J; Mohd Abas MN; Yong CM; Ramasamy V; Md Noor MR; Aliyas I; Lim MCK; Suberamaniam A; Mat Adenan NA; Ahmad ZA; Ho GF; Abdul Malik R; Subramaniam S; Khoo BP; Raja A; Chin YS; Sim WW; Teh BH; Kho SK; Ong ESE; Voon PJ; Ismail G; Lee CL; Abdullah BZ; Loo KS; Lim CS; Lee SJ; Lim KJL; Shafiee MN; Ismail F; Latiff ZA; Ismail MP; Mohamed Jamli MF; Kumarasamy S; Leong KW; Low J; Md Yusof M; Ahmad Mustafa AM; Mat Ali NH; Makanjang M; Tayib S; Cheah N; Lim BK; Fong CK; Foo YC; Mellor Abdullah M; Tan TS; Chow DSY; Ho KF; Raman R; Radzi A; Deniel A; Teoh DCY; Ang SF; Joseph JK; Ng PHO; Tho LM; Ahmad AR; Muin I; Bleiker E; George A; Thong MK; Woo YL; Teo SH
J Med Genet; 2022 Mar; 59(3):220-229. PubMed ID: 33526602
[TBL] [Abstract][Full Text] [Related]
8. Moving into the mainstream: healthcare professionals' views of implementing treatment focussed genetic testing in breast cancer care.
Hallowell N; Wright S; Stirling D; Gourley C; Young O; Porteous M
Fam Cancer; 2019 Jul; 18(3):293-301. PubMed ID: 30689103
[TBL] [Abstract][Full Text] [Related]
9. Mainstream germline genetic testing for patients with epithelial ovarian cancer leads to higher testing rates and a reduction in genetics-related healthcare costs from a healthcare payer perspective.
Bokkers K; Frederix GWJ; Velthuizen ME; van der Aa M; Gerestein CG; van Dorst EBL; Lange JG; Louwers JA; Koole W; Zweemer RP; Ausems MGEM
Gynecol Oncol; 2022 Oct; 167(1):115-122. PubMed ID: 36031452
[TBL] [Abstract][Full Text] [Related]
10. Positive experiences of healthcare professionals with a mainstreaming approach of germline genetic testing for women with ovarian cancer.
Bokkers K; Zweemer RP; Koudijs MJ; Stehouwer S; Velthuizen ME; Bleiker EMA; Ausems MGEM
Fam Cancer; 2022 Jul; 21(3):295-304. PubMed ID: 34617209
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Cancer-Based Criteria for Use in Mainstream BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer.
Kemp Z; Turnbull A; Yost S; Seal S; Mahamdallie S; Poyastro-Pearson E; Warren-Perry M; Eccleston A; Tan MM; Teo SH; Turner N; Strydom A; George A; Rahman N
JAMA Netw Open; 2019 May; 2(5):e194428. PubMed ID: 31125106
[TBL] [Abstract][Full Text] [Related]
12. Mainstream consent programs for genetic counseling in cancer patients: A systematic review.
Scheinberg T; Young A; Woo H; Goodwin A; Mahon KL; Horvath LG
Asia Pac J Clin Oncol; 2021 Jun; 17(3):163-177. PubMed ID: 32309911
[TBL] [Abstract][Full Text] [Related]
13. Mainstream germline genetic testing in men with metastatic prostate cancer: design and protocol for a multicenter observational study.
Vlaming M; Bleiker EMA; van Oort IM; Kiemeney LALM; Ausems MGEM
BMC Cancer; 2022 Dec; 22(1):1365. PubMed ID: 36581909
[TBL] [Abstract][Full Text] [Related]
14. Mainstreaming Genetic Testing for Epithelial Ovarian Cancer by Oncology Providers: A Survey of Current Practice.
Czekalski MA; Huziak RC; Durst AL; Taylor S; Mai PL
JCO Precis Oncol; 2022 Jan; 6():e2100409. PubMed ID: 35025618
[TBL] [Abstract][Full Text] [Related]
15. Uptake of testing for germline
Stearnes G; Nichols CB; Schofield L; O'Sullivan S; Pachter N; Cohen PA
Int J Gynecol Cancer; 2019 Jul; 29(6):1038-1042. PubMed ID: 31101686
[TBL] [Abstract][Full Text] [Related]
16. Mainstreaming germline BRCA1/2 testing in non-mucinous epithelial ovarian cancer in the North West of England.
Flaum N; Morgan RD; Burghel GJ; Bulman M; Clamp AR; Hasan J; Mitchell CL; Badea D; Moon S; Hogg M; Hadjiyiannakis D; Clancy T; Schlecht H; Woodward ER; Crosbie EJ; Edmondson RJ; Wallace AJ; Jayson GC; Lalloo FI; Harkness EF; Evans DGR
Eur J Hum Genet; 2020 Nov; 28(11):1541-1547. PubMed ID: 32651552
[TBL] [Abstract][Full Text] [Related]
17. How can Australia integrate routine genetic sequencing in oncology: a qualitative study through an implementation science lens.
O'Shea R; Rankin NM; Kentwell M; Gleeson M; Salmon L; Tucker KM; Lewis S; Taylor N
Genet Med; 2020 Sep; 22(9):1507-1516. PubMed ID: 32461668
[TBL] [Abstract][Full Text] [Related]
18. Pilot study of an online training program to increase genetic literacy and communication skills in oncology healthcare professionals discussing BRCA1/2 genetic testing with breast and ovarian cancer patients.
Meiser B; Woodward P; Gleeson M; Kentwell M; Fan HM; Antill Y; Butow PN; Boyle F; Best M; Taylor N; Bell K; Tucker K
Fam Cancer; 2022 Apr; 21(2):157-166. PubMed ID: 33970363
[TBL] [Abstract][Full Text] [Related]
19. The development and evaluation of a nationwide training program for oncology health professionals in the provision of genetic testing for ovarian cancer patients.
Gleeson M; Kentwell M; Meiser B; Do J; Nevin S; Taylor N; Barlow-Stewart K; Kirk J; James P; Scott CL; Williams R; Gamet K; Burke J; Murphy M; Antill YC; Pearn A; Pachter N; Ebzery C; Poplawski N; Friedlander M; Tucker KM;
Gynecol Oncol; 2020 Aug; 158(2):431-439. PubMed ID: 32451123
[TBL] [Abstract][Full Text] [Related]
20. Mainstream genetic testing for breast cancer patients: early experiences from the Parkville Familial Cancer Centre.
Beard C; Monohan K; Cicciarelli L; James PA
Eur J Hum Genet; 2021 May; 29(5):872-880. PubMed ID: 33723355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
